Sarah Cannon Research Institute SCRI is a clinical research site located in Jacksonville, Florida, United States 32256.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute SCRI has participated in 1 clinical trials.
Therapeutic areas: Chronic Myelogenous Leukemia in Chronic Phase.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Florida · View every site in Jacksonville
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute SCRI has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute SCRI has 1 clinical trials on record. Their work covers Chronic Myelogenous Leukemia in Chronic Phase.
Sarah Cannon Research Institute SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.